Literature DB >> 15764294

CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: a pooled analysis of gene-gene interactions.

Paolo Vineis1, Fabrizio Veglia, Sisko Anttila, Simone Benhamou, Margie L Clapper, Vita Dolzan, David Ryberg, Ari Hirvonen, Pierre Kremers, Loic Le Marchand, Roberta Pastorelli, Agneta Rannug, Marjorie Romkes, Bernadette Schoket, Richard C Strange, Seymour Garte, Emanuela Taioli.   

Abstract

Gene-environment interactions have been extensively studied in lung cancer. It is likely that several genetic polymorphisms cooperate in increasing the individual risk. Therefore, the study of gene-gene interactions might be important to identify high-susceptibility subgroups. GSEC is an initiative aimed at collecting available data sets on metabolic polymorphisms and the risks of cancer at several sites and performing pooled analyses of the original data. Authors of published papers have provided original data sets. The present paper refers to gene-gene interactions in lung cancer and considers three polymorphisms in three metabolic genes: CYP1A1, GSTM1 and GSTT1. The present analyses compare the gene gene interactions of the CYP1A1*2A, GSTM1 and GSTT1 polymorphisms from studies on lung cancer conducted in Europe and the USA between 1991 and 2000. Only Caucasians have been included. The data set includes 1466 cases and 1488 controls. The only clear-cut association was found with CYP1A1*2A. This association remained unchanged after stratification by polymorphisms in other genes (with an odds ratio [OR] of approximately 2.5), except when interaction with GSTM1 was considered. When the OR for CYP1A1*2A was stratified according to the GSTM1 genotype, the OR was increased only among the subjects who had the null (homozygous deletion) GSTM1 genotype (OR = 2.8, 95% CI = 0.9-8.4). The odds ratio for the interactive term (CYP1A1*2A by GSTM1) in logistic regression was 2.7 (95% CI = 0.5-15.3). An association between lung cancer and the homozygous CYP1A1*2A genotype is confirmed. An apparent and biologically plausible interaction is suggested between this genotype and GSTM1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15764294     DOI: 10.1080/13547500400011070

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  17 in total

Review 1.  CYP1A1 MspI polymorphism and susceptibility to lung cancer in the Chinese population: an updated meta-analysis and review.

Authors:  Xin Wang; Kai Yue; Li-Ran Hao
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  Combined CYP1A1/GSTM1 at-risk genotypes are overrepresented in squamous cell lung carcinoma patients but underrepresented in elderly tumor-free subjects.

Authors:  Evgeniya V Belogubova; Yulia M Ulibina; Irina K Suvorova; Ekatherina Sh Kuligina; Maria B Karpova; Vladimir A Shutkin; Andrey V Koloskov; Alexandr P Kuchinskiy; Alexandr V Togo; Kaido P Hanson; Ari Hirvonen; Evgeny N Imyanitov
Journal:  J Cancer Res Clin Oncol       Date:  2006-01-14       Impact factor: 4.553

3.  Preferential glutathione conjugation of a reverse diol epoxide compared with a bay region diol epoxide of benzo[a]pyrene in human hepatocytes.

Authors:  Pramod Upadhyaya; J Bradley Hochalter; Silvia Balbo; Edward J McIntee; Stephen S Hecht
Journal:  Drug Metab Dispos       Date:  2010-06-14       Impact factor: 3.922

4.  A meta-analysis of the relationship between glutathione S-transferase T1 null/presence gene polymorphism and the risk of lung cancer including 31802 subjects.

Authors:  Hua-Fu Zhou; Xu Feng; Bao-Shi Zheng; Jun Qian; Wei He
Journal:  Mol Biol Rep       Date:  2013-09-26       Impact factor: 2.316

5.  Combined effects of CYP1A1 MspI and GSTM1 genetic polymorphisms on risk of lung cancer: an updated meta-analysis.

Authors:  Wen Li; Li-Qiang Song; Jian Tan
Journal:  Tumour Biol       Date:  2014-06-18

6.  Preferential glutathione conjugation of a reverse diol epoxide compared to a bay region diol epoxide of phenanthrene in human hepatocytes: relevance to molecular epidemiology studies of glutathione-s-transferase polymorphisms and cancer.

Authors:  Stephen S Hecht; Jeannette Zinggeler Berg; J Bradley Hochalter
Journal:  Chem Res Toxicol       Date:  2009-03-16       Impact factor: 3.739

Review 7.  Molecular epidemiology to better predict lung cancer risk.

Authors:  Mary E Reid; Regina Santella; Christine B Ambrosone
Journal:  Clin Lung Cancer       Date:  2008-05       Impact factor: 4.785

8.  Analysis of phenanthrene diol epoxide mercapturic acid detoxification products in human urine: relevance to molecular epidemiology studies of glutathione S-transferase polymorphisms.

Authors:  Stephen S Hecht; Peter W Villalta; J Bradley Hochalter
Journal:  Carcinogenesis       Date:  2008-05-13       Impact factor: 4.944

Review 9.  Progress in the epidemiological understanding of gene-environment interactions in major diseases: cancer.

Authors:  Jacqueline Clavel
Journal:  C R Biol       Date:  2007-04-05       Impact factor: 1.583

10.  Association between glutathione S-transferase T1 null genotype and risk of lung cancer: a meta-analysis of 55 studies.

Authors:  Hongmei Yang; Xiaoyu Shen; Binru Li; Rui Ma
Journal:  Tumour Biol       Date:  2013-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.